Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREAT NOW: Lopinavir/Ritonavir for Early COVID-19
NCT04372628Phase 2Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Jun 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lopinavir + ritonavir in coronavirus disease 2019 (COVID-19), sponsored by Vanderbilt University Medical Center. Started Jun 2020; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04372628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04372628.